Clinical Study
Emotion Processing in Women with Schizophrenia Is Menstrual Cycle Phase and Affective Valence Dependent: An fMRI Study
Table 1
Demographic, clinical, and hormonal characteristics of control and schizophrenia women.
| | Control women | Schizophrenia women | | | () | () | P | | M | SD | M | SD | |
| | Demographic | | | | | | | āAge (years) | 29.28 | 9.27 | 32.86 | 6.56 | 0.138 | | āParental SES | 2.08 | 1.10 | 2.55 | 1.05 | 0.145 | | Clinical | | | | | | | āPANSS positive | ā | ā | 19.32 | 7.82 | ā | | āPANSS negative | ā | ā | 20.14 | 8.69 | ā | | āPANSS general | ā | ā | 42.27 | 12.71 | ā | | āMedication (mg/day) | ā | ā | 496.61 | 267.94 | ā | | Hormonal | | | | | | | āEstrogen (pmol/L) | 256.42 | 265.38 | 214.90 | 150.80 | 0.525 | | āProgesterone (nmol/L) | 12.93 | 19.37 | 8.66 | 10.98 | 0.371 |
|
|
M: mean; SD: standard deviation; SES: socioeconomic status; Medication: equivalence in chlorpromazine.
|
